Business Context and Reporting Period
Company: GlaxoSmithKline plc
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: October 15, 2013
This filing reports a blocklisting application submitted to the Financial Conduct Authority and the London Stock Exchange Plc. The company seeks admission to the Official List for 20,010,000 Ordinary shares of 25p each.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance filing regarding share issuance and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document details a planned increase in share capital through the reservation of shares under specific employee incentive schemes.
Guidance, Outlook, and Risks
Share Issuance Details: The 20,010,000 shares are reserved under block listings for issuance pursuant to the following schemes:
- GlaxoSmithKline Share Option Plan - Ordinary shares: 10,000,000
- GlaxoSmithKline Share Option Plan - ADS: 10,000,000
- GlaxoSmithKline plc Sharesave plan 2012: 10,000
Investor Verification Checklist
- Confirm the final admission of the 20,010,000 shares to the Official List.
- Verify the actual issuance dates and quantities under the Share Option Plan and Sharesave plan.
- Review the company's most recent Form 20-F or quarterly report for actual financial performance metrics, as they are absent from this filing.